Intellectual Property India Publishes Patent Application for Crystalline Forms Of A2a Receptor Antagonist, Preparation Methods, And Uses Thereof

MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202617084283 A) filed by Johnson & Johnson Enterprise Innovation Inc. on July 09, 2026, for Crystalline Forms Of A2a Receptor Antagonist, Preparation Methods, And Uses Thereof.

Inventors include Ng, Alicia Tee Fuay; Mcqueen, Lisa; and Tieger, Eszter.

The application for the patent was published on October 09, 2026, under issue no. 41/2026.

Abstract: Disclosed are crystalline forms of the A2A receptor antagonist 2-(3-cyanophenyl)- 3-(2,6-dimethylpyridin-4-yl)-N-[(2S)-3-hydroxy-3-methylbutan-2-yl] pyrazolo[1,5- a]pyrimidine-5-carboxamide, and preparation methods and uses thereof.

Disclaimer: Curated by HT Syndication....